Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03117582 · ClinicalTrials.gov registry record
Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 34
- Enrollment target
NCT03117582 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 34 participants.
The verdict
NCT03117582 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
Purpose: To study the changes in the microbiome and stool composition in patients with Clostridium Difficile Infection (CDI) who undergo Fecal Microbiota Transplantation (FMT), along with changes in their clinical characteristics.
Interventions
- OTHER Stool specimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2016-12 |
| Est. Completion | 2020-12-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03117582
The ClinicalTrials.gov registry entry for NCT03117582 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stool specimen is the first listed.
NCT03117582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03117582 about?
NCT03117582 is a clinical study titled "Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics". Purpose: To study the changes in the microbiome and stool composition in patients with Clostridium Difficile Infection (CDI) who undergo Fecal Microbiota Transplantation (FMT), along with changes in their clinical characteristics.
What is the current status of trial NCT03117582?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2016-12. Estimated completion is 2020-12-11.
What interventions are being tested in trial NCT03117582?
The interventions under investigation include: Stool specimen (OTHER).
Who is sponsoring clinical trial NCT03117582?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.